When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Sarcopenia

Last reviewed: 18 Jan 2026
Last updated: 27 Sep 2023

Summary

Definition

History and exam

Key diagnostic factors

  • low hand grip strength
  • difficulty rising from chair
  • difficulty climbing stairs
  • slow gait
  • emaciation
  • difficulty performing activities of daily living
Full details

Other diagnostic factors

  • presence of comorbidities affecting muscle mass and/or function
Full details

Risk factors

  • age ≥65 years
  • low or high body mass index (BMI)
  • sedentary lifestyle
  • low protein intake
  • falls
  • smoking
Full details

Diagnostic investigations

1st investigations to order

  • serum electrolytes
  • blood glucose
  • LFTs
  • renal function tests
  • thyroid function tests
  • CBC
  • serum vitamin D
  • dual-energy x-ray absorptiometry (DXA)
  • CT
  • MRI
Full details

Investigations to consider

  • bioimpedance analysis (BIA)
Full details

Treatment algorithm

ACUTE

all patients

Contributors

Authors

Gustavo Duque, MD, PhD

Professor

Faculty of Medicine

McGill University

Quebec

Canada

Disclosures

GD serves as a member of the Advisory Boards of Abbott Australia and TSI Pharmaceuticals. He also belongs to the speakers' bureau for Amgen and Abbott Australia. These companies produce therapeutic compounds that have demonstrated an effect on sarcopenia

Guy Hajj-Boutros, PhD(c)

PhD candidate

Division of Experimental Medicine

McGill University

Quebec

Canada

Declarações

GHB declares that he has no competing interests.

José A. Morais, MD

Professor

Faculty of Medicine

McGill University

Quebec

Canada

Declarações

JAM has served as a consultant for Structure Therapeutics, USA. He has received operating grants from the Canadian Institutes of Health Research. JAM has also performed contracted research for Amazentis, Switzerland.

Revisores

Stephanie Anne Studenski, MD, MPH

Professor Emeritus

Department of Medicine

University of Pittsburgh

Pittsburgh

PA

Divulgaciones

SAS declares that she has no competing interests.

Miles Witham, PhD

Professor of Trials for Older People and consultant geriatrician

NIHR Newcastle Biomedical Research Centre

Newcastle University

Newcastle

UK

Divulgaciones

MW declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

​Cruz-Jentoft AJ, Bahat G, Bauer J, et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31.Texto completo  Resumen

​Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018;22(10):1148-61. Resumen

​Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. 2020 Jul;68(7):1410-8. Resumen

Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-7. Resumen

Izquierdo M, Merchant RA, Morley JE, et al. International exercise recommendations in older adults (ICFSR): expert consensus guidelines. J Nutr Health Aging. 2021;25(7):824-53.Texto completo  Resumen

​Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Differentials

    • Parkinson disease
    • Amyotrophic lateral sclerosis
    • Myopathy
    More Differentials
  • Guidelines

    • Sarcopenia: revised European consensus on definition and diagnosis
    • International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer